EXSERVAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Exservan, and what generic alternatives are available?
Exservan is a drug marketed by Mitsubishi Holdings and is included in one NDA. There are two patents protecting this drug.
This drug has one hundred and sixty-two patent family members in nineteen countries.
The generic ingredient in EXSERVAN is riluzole. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the riluzole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Exservan
A generic version of EXSERVAN was approved as riluzole by IMPAX LABS on January 29th, 2003.
Summary for EXSERVAN
| International Patents: | 162 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for EXSERVAN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EXSERVAN |
| What excipients (inactive ingredients) are in EXSERVAN? | EXSERVAN excipients list |
| DailyMed Link: | EXSERVAN at DailyMed |
Pharmacology for EXSERVAN
| Drug Class | Benzothiazole |
Anatomical Therapeutic Chemical (ATC) Classes for EXSERVAN
US Patents and Regulatory Information for EXSERVAN
EXSERVAN is protected by two US patents.
Patents protecting EXSERVAN
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mitsubishi Holdings | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Mitsubishi Holdings | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EXSERVAN
See the table below for patents covering EXSERVAN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 2002362772 | See Plans and Pricing | |
| Canada | 2468557 | EMBALLAGE DESTINE DES COMPOSANTS ELECTRO-OPTIQUES (PACKAGE FOR ELECTRO-OPTICAL COMPONENTS) | See Plans and Pricing |
| European Patent Office | 2335921 | Films multicouches (Multi-layer films) | See Plans and Pricing |
| Canada | 2581851 | FILMS MULTICOUCHES PRESENTANT UN CONTENU UNIFORME (MULTI-LAYER FILMS HAVING UNIFORM CONTENT) | See Plans and Pricing |
| European Patent Office | 2120897 | FILMS À BASE DE POLYMÈRES ET SYSTÈMES DE DÉLIVRANCE DE MÉDICAMENTS FABRIQUÉS À PARTIR DE CEUX-CI (POLYMER-BASED FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM) | See Plans and Pricing |
| Japan | 2011068689 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE FROM THE SAME | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
